全文获取类型
收费全文 | 5294篇 |
免费 | 329篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 130篇 |
妇产科学 | 53篇 |
基础医学 | 848篇 |
口腔科学 | 140篇 |
临床医学 | 506篇 |
内科学 | 1146篇 |
皮肤病学 | 161篇 |
神经病学 | 513篇 |
特种医学 | 248篇 |
外科学 | 775篇 |
综合类 | 21篇 |
一般理论 | 2篇 |
预防医学 | 281篇 |
眼科学 | 48篇 |
药学 | 409篇 |
中国医学 | 4篇 |
肿瘤学 | 318篇 |
出版年
2023年 | 21篇 |
2022年 | 39篇 |
2021年 | 97篇 |
2020年 | 74篇 |
2019年 | 96篇 |
2018年 | 145篇 |
2017年 | 109篇 |
2016年 | 140篇 |
2015年 | 113篇 |
2014年 | 155篇 |
2013年 | 232篇 |
2012年 | 306篇 |
2011年 | 325篇 |
2010年 | 220篇 |
2009年 | 205篇 |
2008年 | 322篇 |
2007年 | 334篇 |
2006年 | 295篇 |
2005年 | 277篇 |
2004年 | 258篇 |
2003年 | 263篇 |
2002年 | 230篇 |
2001年 | 68篇 |
2000年 | 72篇 |
1999年 | 73篇 |
1998年 | 53篇 |
1997年 | 46篇 |
1996年 | 31篇 |
1995年 | 26篇 |
1994年 | 35篇 |
1993年 | 22篇 |
1992年 | 44篇 |
1991年 | 46篇 |
1990年 | 45篇 |
1989年 | 46篇 |
1988年 | 36篇 |
1987年 | 32篇 |
1986年 | 36篇 |
1985年 | 39篇 |
1984年 | 43篇 |
1983年 | 31篇 |
1982年 | 26篇 |
1980年 | 23篇 |
1979年 | 29篇 |
1978年 | 39篇 |
1977年 | 32篇 |
1975年 | 26篇 |
1974年 | 23篇 |
1972年 | 22篇 |
1971年 | 23篇 |
排序方式: 共有5657条查询结果,搜索用时 351 毫秒
131.
132.
133.
134.
135.
Luise Aamann Else Marie Vestergaard Henning Grφnbk 《World journal of gastroenterology : WJG》2014,20(12):3223-3230
Inflammatory bowel disease(IBD),which comprises ulcerative colitis and Crohn’s disease,is characterized by inflammation of the gastrointestinal tract.The trefoil factors 1,2,and 3(TFF1-3)are a family of peptides that play important roles in the protection and repair of epithelial surfaces,including the gastrointestinal tract.TFFs may be involved in IBD pathogenesis and are a potential treatment option.In the present review,we describe the TFF family and their potential role in IBD by summarizing the current knowledge of their expression,possible function and pharmacological role in IBD. 相似文献
136.
Toni Urbanik Bruno Christian Koehler Laura Wolpert Christin El?ner Anna-Lena Scherr Thomas Longerich Nicole Kautz Stefan Welte Nadine H?velmeyer Dirk J?ger Ari Waisman Henning Schulze-Bergkamen 《World journal of gastroenterology : WJG》2014,20(45):17049-17064
AIM:To analyze the role of CYLD for receptor-mediated cell death of murine hepatocytes in acute liver injury models.METHODS:Hepatocyte cell death in CYLD knockout mice(CYLD-/-)was analyzed by application of liver injury models for CD95-(Jo2)and tumor necrosis factor(TNF)-α-[D-Gal N/lipopolysaccharide(LPS)]induced apoptosis.Liver injury was assessed by measurement of serum transaminases and histological analysis.Apoptosis induction was quantified by cleaved PARP staining and Western blotting of activated caspases.Nuclear factor(NF)-κB,ERK,Akt and jun amino-terminal kinases signaling were assessed.Primary Hepatocytes were isolated by two step-collagenase perfusion and treated with recombinant TNF-αand with the CD95-ligand Jo2.Cell viability was analyzed by MTT-assay.RESULTS:Livers of CYLD-/-mice showed increased anti-apoptotic NF-κB signaling.In both applied liver injury models CYLD-/-mice showed a significantly reduced apoptosis sensitivity.After D-Gal N/LPS treatment CYLD-/-mice exhibited significantly lower levels of alanine aminotransferase(ALT)(295 U/L vs 859 U/L,P<0.05)and aspartate aminotransferase(AST)(560 U/L vs 1025 U/L,P<0.01).After Jo injection CYLD-/-mice showed 2-fold lower ALT(50 U/L vs 110 U/L,P<0.01)and lower AST(250 U/L vs 435 U/L,P<0.01)serumlevels compared to WT mice.In addition,isolated CYLD-/-primary murine hepatocytes(PMH)were less sensitive towards death receptor-mediated apoptosis and showed increased levels of Bcl-2,XIAP,c IAP1/2,survivin and c-FLIP expression upon TNF-and CD95-receptor triggering,respectively.Inhibition of NF-κB activation by the inhibitor of NF-κB phosphorylation inhibitor BAY 11-7085 inhibited the expression of antiapoptotic proteins and re-sensitized CYLD-/-PMH towards TNF-and CD95-receptor mediated cell death.CONCLUSION:CYLD is a central regulator of apoptotic cell death in murine hepatocytes by controlling NF-κB dependent anti-apoptotic signaling. 相似文献
137.
Sara Heebll Karen Louise Thomsen Steen B Pedersen Hendrik Vilstrup Jacob George Henning Grnbk 《World journal of hepatology》2014,6(4):188-198
The prevalence of obesity and related conditions like non-alcoholic fatty liver disease(NAFLD) is increasing worldwide and therapeutic options are limited.Alternative treatment options are therefore intensively sought after.An interesting candidate is the natural polyphenol resveratrol(RSV) that activates adenosinmonophosphate-activated protein kinase(AMPK) and silent information regulation-2 homolog 1(SIRT1).In addition,RSV has known anti-oxidant and anti-inflammatory effects.Here,we review the current evidence for RSVmediated effects on NAFLD and address the different aspects of NAFLD and non-alcoholic steatohepatitis(NASH) pathogenesis with respect to free fatty acid(FFA) flux from adipose tissue,hepatic de novo lipogenesis,inadequate FFA β-oxidation and additional intra- and extrahepatic inflammatory and oxidant hits.We review the in vivo evidence from animal studies and clinical trials.The abundance of animal studies reports a decrease in hepatic triglyceride accumulation,liver weight and a general improvement in histological fatty liver changes,along with a reduction in circulating insulin,glucose and lipid levels.Some studies document AMPK or SIRT1 activation,and modulation of relevant markers of hepatic lipogenesis,inflammation and oxidation status.However,AMPK/SIRT1-independent actions are also likely.Clinical trials are scarce and have primarily been performed with a focus on overweight/obese participants without a focus on NAFLD/NASH and histological liver changes.Future clinical studies with appropriate design are needed to clarify the true impact of RSV treatment in NAFLD/NASH patients. 相似文献
138.
139.
140.
Busche MA Chen X Henning HA Reichwald J Staufenbiel M Sakmann B Konnerth A 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(22):8740-8745
Alzheimer's disease (AD) is characterized by a progressive dysfunction of central neurons. Recent experimental evidence indicates that in the cortex, in addition to the silencing of a fraction of neurons, other neurons are hyperactive in amyloid-β (Aβ) plaque-enriched regions. However, it has remained unknown what comes first, neuronal silencing or hyperactivity, and what mechanisms might underlie the primary neuronal dysfunction. Here we examine the activity patterns of hippocampal CA1 neurons in a mouse model of AD in vivo using two-photon Ca(2+) imaging. We found that neuronal activity in the plaque-bearing CA1 region of older mice is profoundly altered. There was a marked increase in the fractions of both silent and hyperactive neurons, as previously also found in the cortex. Remarkably, in the hippocampus of young mice, we observed a selective increase in hyperactive neurons already before the formation of plaques, suggesting that soluble species of Aβ may underlie this impairment. Indeed, we found that acute treatment with the γ-secretase inhibitor LY-411575 reduces soluble Aβ levels and rescues the neuronal dysfunction. Furthermore, we demonstrate that direct application of soluble Aβ can induce neuronal hyperactivity in wild-type mice. Thus, our study identifies hippocampal hyperactivity as a very early functional impairment in AD transgenic mice and provides direct evidence that soluble Aβ is crucial for hippocampal hyperactivity. 相似文献